CPEB3 has been shown to inhibit the progression of gastrointestinal and hepatic cancers by regulating mRNA translation, whereas RCL1 is suggested to act as a tumor suppressor via ribosome biogenesis modulation. This evidence concerns the gene RCL1 and neoplasm.